Effectiveness for endothelial function after administration of tadarafil for men with urinary and sexual symptoms
Not Applicable
- Conditions
- benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000009580
- Lead Sponsor
- Department of Urology Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients Received nitrate drug 2 Patients has organic disease other than BPH, that was prostate cancer,bladder tumor, bladder stone, prostatitis, urethral stenosis et al. 3 Patients were performed urological surgery before 6 months. 4 Patients have active urinary infection. 5 Patients has neurogenic bladder. 6 Patients has severe ischemic coronary disease, cerebrovascular accident, liver dysfunction, renal dysfunction. 7 Patients has hypotension. 8 Doctor has other patients deemed inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the vascular endothelial function before and after recieved tadalafil at 5mg a day 12 weeks.
- Secondary Outcome Measures
Name Time Method